Related references
Note: Only part of the references are listed.Algorithms can be used to identify fragility fracture cases in physician-claims databases
S. Jean et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Adverse Reactions and Drug-Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
Rene Rizzoli et al.
CALCIFIED TISSUE INTERNATIONAL (2011)
Fracture prediction and calibration of a Canadian FRAXA® tool: a population-based report from CaMos
L-A. Fraser et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Construction of a FRAXA® model for the assessment of fracture probability in Canada and implications for treatment
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts
W. D. Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2011)
A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Interpretation and use of FRAX in clinical practice
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Osteoporosis: burden, health care provision and opportunities in the EU
O. Ström et al.
Archives of Osteoporosis (2011)
A Before-and-After Study of Fracture Risk Reporting and Osteoporosis Treatment Initiation
William D. Leslie et al.
ANNALS OF INTERNAL MEDICINE (2010)
A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRA®
John A. Kanis et al.
BONE (2010)
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Alexandra Papaioannou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Independent Clinical Validation of a Canadian FRAX Tool: Fracture Prediction and Model Calibration
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Updated fracture incidence rates for the US version of FRAXA (R)
B. Ettinger et al.
OSTEOPOROSIS INTERNATIONAL (2010)
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Effectiveness of bisphosphonate therapy in a community setting
Adrianne C. Feldstein et al.
BONE (2009)
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®
John A. Kanis et al.
BONE (2009)
Identification and Validation of Vertebral Compression Fractures Using Administrative Claims Data
Jeffrey R. Curtis et al.
MEDICAL CARE (2009)
Ten-year fracture probability identifies women who will benefit from clodronate therapy-additional results from a double-blind, placebo-controlled randomised study
E. V. McCloskey et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Systematic review: Comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis
Catherine MacLean et al.
ANNALS OF INTERNAL MEDICINE (2008)
A reference standard for the description of osteoporosis
John A. Kanis et al.
BONE (2008)
Commentary: A revised clinician's guide to the prevention and treatment of osteoporosis
Bess Dawson-Hughes
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
B. Dawson-Hughes et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Effectiveness of bone density measurement for predicting osteoporotic fractures in clinical practice
William D. Leslie et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
E. Seeman
BONE (2007)
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies
S Boonen et al.
OSTEOPOROSIS INTERNATIONAL (2005)
A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service
WD Leslie et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Quality of life in patients with osteoporosis
P Lips et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Construction and validation of a population-based bone densitometry database
WD Leslie et al.
JOURNAL OF CLINICAL DENSITOMETRY (2005)
Recalculation of the NHANES database SD improves T-score agreement and reduces osteoporosis prevalence
N Binkley et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Bone density monitoring with the total hip site
WD Leslie et al.
JOURNAL OF CLINICAL DENSITOMETRY (2004)
A note on competing risks in survival data analysis
JM Satagopan et al.
BRITISH JOURNAL OF CANCER (2004)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs
SR Cummings et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Share Paper
